BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15483462)

  • 41. Development of a cytotoxic T-cell assay in rabbits to evaluate early immune response to human T-lymphotropic virus type 1 infection.
    Haynes RA; Phipps AJ; Yamamoto B; Green P; Lairmore MD
    Viral Immunol; 2009 Dec; 22(6):397-405. PubMed ID: 19951176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation and detection of HTLV-I Tax-specific CTLs by epitope expressing single-chain trimers of MHC class I in a rat model.
    Ohashi T; Nagai M; Okada H; Takayanagi R; Shida H
    Retrovirology; 2008 Oct; 5():90. PubMed ID: 18840303
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation of major histocompatibility complex class I downregulation with resistance of human T-cell leukemia virus type 1-infected T cells to cytotoxic T-lymphocyte killing in a rat model.
    Ohashi T; Hanabuchi S; Suzuki R; Kato H; Masuda T; Kannagi M
    J Virol; 2002 Jul; 76(14):7010-9. PubMed ID: 12072501
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunogenicity of nonreplicating recombinant vaccinia expressing HLA-A201 targeted or complete MART-1/Melan-A antigen.
    Schütz A; Oertli D; Marti WR; Noppen C; Padovan E; Spagnoli GC; Heberer M; Zajac P
    Cancer Gene Ther; 2001 Sep; 8(9):655-61. PubMed ID: 11593334
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines.
    Livingston BD; Newman M; Crimi C; McKinney D; Chesnut R; Sette A
    Vaccine; 2001 Sep; 19(32):4652-60. PubMed ID: 11535313
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells.
    Tanaka Y; Yamazaki R; Terasako-Saito K; Nakasone H; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Kimura S; Kikuchi M; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
    Immunol Lett; 2014; 158(1-2):120-5. PubMed ID: 24389072
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential contribution of a novel Tax epitope-specific CD4+ T cells to graft-versus-Tax effect in adult T cell leukemia patients after allogeneic hematopoietic stem cell transplantation.
    Tamai Y; Hasegawa A; Takamori A; Sasada A; Tanosaki R; Choi I; Utsunomiya A; Maeda Y; Yamano Y; Eto T; Koh KR; Nakamae H; Suehiro Y; Kato K; Takemoto S; Okamura J; Uike N; Kannagi M
    J Immunol; 2013 Apr; 190(8):4382-92. PubMed ID: 23475215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
    Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
    J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Presentation of human T cell leukemia virus type 1 (HTLV-1) Tax protein by dendritic cells: the underlying mechanism of HTLV-1-associated neuroinflammatory disease.
    Manuel SL; Schell TD; Acheampong E; Rahman S; Khan ZK; Jain P
    J Leukoc Biol; 2009 Nov; 86(5):1205-16. PubMed ID: 19656902
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice.
    Lacey SF; La Rosa C; Kaltcheva T; Srivastava T; Seidel A; Zhou W; Rawal R; Hagen K; Krishnan A; Longmate J; Andersson HA; St John L; Bhatia R; Pullarkat V; Forman SJ; Cooper LJ; Molldrem J; Diamond DJ
    Blood; 2011 Aug; 118(8):2159-69. PubMed ID: 21719601
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conserved CDR3 regions in T-cell receptor (TCR) CD8(+) T cells that recognize the Tax11-19/HLA-A*0201 complex in a subject infected with human T-cell leukemia virus type 1: relationship of T-cell fine specificity and major histocompatibility complex/peptide/TCR crystal structure.
    Bourcier KD; Lim DG; Ding YH; Smith KJ; Wucherpfennig K; Hafler DA
    J Virol; 2001 Oct; 75(20):9836-43. PubMed ID: 11559817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of the V3 loop deletion of envelope glycoprotein on cellular responses and protection against challenge with recombinant vaccinia virus expressing gp160 of primary human immunodeficiency virus type 1 isolates.
    Kiszka I; Kmieciak D; Gzyl J; Naito T; Bolesta E; Sieron A; Singh SP; Srinivasan A; Trinchieri G; Kaneko Y; Kozbor D
    J Virol; 2002 May; 76(9):4222-32. PubMed ID: 11932387
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.
    Jacobson S; Shida H; McFarlin DE; Fauci AS; Koenig S
    Nature; 1990 Nov; 348(6298):245-8. PubMed ID: 2146511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses.
    Terajima M; Cruz J; Raines G; Kilpatrick ED; Kennedy JS; Rothman AL; Ennis FA
    J Exp Med; 2003 Apr; 197(7):927-32. PubMed ID: 12668642
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
    Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S
    J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intracellular delivery of a novel multiepitope peptide vaccine by an amphipathic peptide carrier enhances cytotoxic T-cell responses in HLA-A*201 mice.
    Dakappagari NK; Sundaram R; Rawale S; Liner A; Galloway DR; Kaumaya PT
    J Pept Res; 2005 Feb; 65(2):189-99. PubMed ID: 15705163
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation.
    Harashima N; Kurihara K; Utsunomiya A; Tanosaki R; Hanabuchi S; Masuda M; Ohashi T; Fukui F; Hasegawa A; Masuda T; Takaue Y; Okamura J; Kannagi M
    Cancer Res; 2004 Jan; 64(1):391-9. PubMed ID: 14729650
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A polytope DNA vaccine elicits multiple effector and memory CTL responses and protects against human papillomavirus 16 E7-expressing tumour.
    Doan T; Herd K; Ramshaw I; Thomson S; Tindle RW
    Cancer Immunol Immunother; 2005 Feb; 54(2):157-71. PubMed ID: 15480657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo and in vitro immunogenicity of novel MHC class I presented epitopes to confer protective immunity against chronic HTLV-1 infection.
    Mulherkar R; Karabudak A; Ginwala R; Huang X; Rowan A; Philip R; Murphy EL; Clements D; Ndhlovu LC; Khan ZK; Jain P
    Vaccine; 2018 Aug; 36(33):5046-5057. PubMed ID: 30005946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.